Replies to post #236827 on Biotech Values

[DewDiligence]

ADMP cheesy PR:

https://www.globenewswire.com/news-release/2022/02/28/2393038/32832/en/Adamis-Pharmaceuticals-Clinical-Study-Assessing-Tempol-for-the-Treatment-of-COVID-19-Surpasses-Enrollment-Expectations.html